Literature DB >> 10051405

Genomic organization and chromosomal localization of the human histone deacetylase 3 gene.

U Mahlknecht1, S Emiliani, V Najfeld, S Young, E Verdin.   

Abstract

Reversible acetylation of histone proteins plays a critical role in transcriptional regulation, cell cycle progression, and developmental events. The steady state of histone acetylation is controlled by the enzymatic activities of multiple histone acetyltransferases and histone deacetylases (HDACs). Three distinct human HDACs are homologous to RPD3, a yeast transcriptional regulator. We have isolated and sequenced a genomic clone for the human HDAC3 gene. This is a single-copy gene spanning a region of at least 13 kb. Determination of the intron-exon splice junctions established that the gene is encoded by 15 exons ranging in size from 56 to 657 bp. Fluorescence in situ hybridization studies localized this gene to 5q31. Double-target experiments in which both HDAC3 and the early-growth response 1 gene (EGR1), which is localized in the 5q31.2 region, were used as probes showed that the HDAC3 gene lies in region 5q31.3, immediately distal to EGR1 with respect to the centromere. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051405     DOI: 10.1006/geno.1998.5645

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Hdac3 is essential for the maintenance of chromatin structure and genome stability.

Authors:  Srividya Bhaskara; Sarah K Knutson; Guochun Jiang; Mahesh B Chandrasekharan; Andrew J Wilson; Siyuan Zheng; Ashwini Yenamandra; Kimberly Locke; Jia-Ling Yuan; Alyssa R Bonine-Summers; Christina E Wells; Jonathan F Kaiser; M Kay Washington; Zhongming Zhao; Florence F Wagner; Zu-Wen Sun; Fen Xia; Edward B Holson; Dineo Khabele; Scott W Hiebert
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

2.  miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.

Authors:  Youngmi Kim; Hyuna Kim; Hyunmi Park; Deokbum Park; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

Review 3.  Complex neuroprotective and neurotoxic effects of histone deacetylases.

Authors:  Elizabeth A Thomas; Santosh R D'Mello
Journal:  J Neurochem       Date:  2018-04-06       Impact factor: 5.372

4.  Cloning and characterization of a novel human histone deacetylase, HDAC8.

Authors:  J J Buggy; M L Sideris; P Mak; D D Lorimer; B McIntosh; J M Clark
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

5.  Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways.

Authors:  S G Gray; A H Iglesias; B T Teh; F Dangond
Journal:  Gene Expr       Date:  2003

6.  Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.

Authors:  Youngmi Kim; Hyuna Kim; Dooil Jeoung
Journal:  Mol Cells       Date:  2015-07-01       Impact factor: 5.034

7.  miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3.

Authors:  Youngmi Kim; Hyuna Kim; Deokbum Park; Dooil Jeoung
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

Review 8.  Transcription and beyond: the role of mammalian class I lysine deacetylases.

Authors:  Mirjam Andrea Moser; Astrid Hagelkruys; Christian Seiser
Journal:  Chromosoma       Date:  2013-10-30       Impact factor: 4.316

9.  Nuclear localization signal domain of HDAC3 is necessary and sufficient for the expression regulation of MDR1.

Authors:  Hyunmi Park; Youngmi Kim; Deokbum Park; Dooil Jeoung
Journal:  BMB Rep       Date:  2014-06       Impact factor: 4.778

10.  HDAC3 acts as a negative regulator of angiogenesis.

Authors:  Deokbum Park; Hyunmi Park; Youngmi Kim; Hyuna Kim; Dooil Jeoung
Journal:  BMB Rep       Date:  2014-04       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.